Gossamer Bio: Funding, Investors & Team (Sep 2026)
Gossamer Bio is a San Diego-put together organization centered with respect to the revelation and improvement of novel and separated remedial items, to address high neglected needs among different designated patient populaces. Established by the previous Receptos chief group, Gossamer Bio's system will be to use a resource rich in-permitting climate, with an emphasis on areas of high neglected need, using a group with major areas of strength for a record of execution in immunology, irritation, fibrosis and oncology.
Gossamer Bio has raised $120M across 1 funding round on record, the most recent a Post-IPO Equity of $120M announced in Jul 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Gossamer Bio Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Gossamer Bio Funding Rounds
Gossamer Bio Founders and Leadership Team
No contact details are on record for this team yet.
Gossamer Bio Funding Compared to Other Biotechnology Startups
Gossamer Bio's latest round of $120M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Gossamer Bio in Biotechnology and San Diego
Companies Similar to Gossamer Bio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Gossamer Bio Funding FAQs
What does Gossamer Bio do?
Gossamer Bio is a San Diego-put together organization centered with respect to the revelation and improvement of novel and separated remedial items, to address high neglected needs among different designated patient populaces. Established by the previous Receptos chief group, Gossamer Bio's system will be to use a resource rich in-permitting climate, with an emphasis on areas of high neglected need, using a group with major areas of strength for a record of execution in immunology, irritation, fibrosis and oncology.
How much funding has Gossamer Bio raised?
Gossamer Bio has raised $120M across 1 round on record. The most recent is a Post-IPO Equity of $120M announced in Jul 2022.
When did Gossamer Bio last raise funding?
Gossamer Bio's most recent funding round on record is a Post-IPO Equity of $120M, announced in Jul 2022.
Who is the CEO of Gossamer Bio?
Sheila Gujrathi is listed as CEO at Gossamer Bio.
Where is Gossamer Bio headquartered?
Gossamer Bio is based in San Diego, California, United States.
How many employees does Gossamer Bio have?
Gossamer Bio is in the 101-250 employee band.
How does Gossamer Bio's funding compare to other Biotechnology startups?
Gossamer Bio's latest round of $120M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Gossamer Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Gossamer Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.